Progressive supranuclear palsy (PSP) is a complex clinicopathologic disease with no
current cure or disease modulating therapies that can only be definitively confirmed at …

Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS; the most common
phenotype of corticobasal degeneration) are tauopathies with a relentless course, usually …

It is believed that glycogen synthase kinase‐3 (GSK‐3) hyperphosphorylates tau protein in
progressive supranuclear palsy (PSP). The Tau Restoration on PSP (TAUROS) study was a …

Objective: To determine pathologic regulations and potential compensatory mechanisms in
the supraspinal locomotor network of patients with progressive supranuclear palsy (PSP) by …

Gaze in real-world scenarios is controlled by a huge variety of parameters, such as stimulus
features, instructions or context, all of which have been studied systematically in laboratory …

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are
neurodegenerative tauopathies with neuronal and glial lesions composed of tau that is …

Background: The decreased ability to carry out vertical saccades is a key symptom of
Progressive Supranuclear Palsy (PSP). Objective measurement devices can help to reliably …

Gait impairment is a core feature of Parkinson's disease (PD) which has been linked to
cognitive and visual deficits, but interactions between these features are poorly understood …

Human locomotion involves a complex interplay among multiple brain regions and depends
on constant feedback from the visual system. We summarize here the current understanding …

Objective: To conduct a systematic review to evaluate exercise and structured physical
activity for people living with Progressive Supranuclear Palsy. Data sources: AMED …